Olive_Logo

Healthcare of the future

It’s time for Olive to help people take control of their health and take the necessary steps toward preventing cancer.

Our mission

One of the most severe issues facing the healthcare system in America today is the lack of access to adequate and affordable healthcare. In fact, nearly 1 in 4 Americans say that they have skipped necessary visits to the doctor or medical tests due to their expense. Olive aims to change that.
Our mission is to make DNA testing accessible and affordable to every person on the planet. With precision genetics, our team can change the world.

Cancer is scary. You don’t have to do it alone.

Olive has developed the patent-pending pipelines that run simultaneously to produce a high-definition genomic risk evaluation that is not only highly accurate but incredibly secure

360° AI Assessment

Olive is the only DNA test that uses polygenic risk scoring and a 360° AI Assessment to identify your risk level for the most deadly cancers. We also provide a comprehensive report you can use with your health care professional to reduce your risk of developing cancer.

Access to Genetic Counselor

You will have 24/7 access to your personal genetic counselor, who will guide you through the process of understanding your risks. Olive is a revolutionary way to understand your genetics. We will make a difference in your life by helping you make informed decisions about your health.

The power of AI technology

PRomiSe®- Polygenic Risk Scoring

In recent years, research has shown that disease risk is not based on one single gene but is also influenced by various genes acting together. To truly understand actual disease risk, we must look at information from the whole genome.
That’s why Olive uses our state-of-the-art, whole-genome PRomiSe® technology to provide a highly accurate and comprehensive analysis of what is known as your “Polygenic Risk Score,” or PRS. The PRomiSe® pipeline is a stable and robust method for calculating a PRS for multiple phenotypes simultaneously.

PREDICTion® - HLA Imputation

HLA Imputation is a way to predict with high probability the missing pieces of the HLA genome by referring to portions of SNP data. Olive employs two proprietary methods of imputation:
CookHLA® is a state-of-the-art imputation method with one of the highest accuracy rates out of any other process in the world (97.5%). It works by translating multi-allelic HLA information into a set of binary markers to use a standard imputation algorithm. It then employs a one-of-a-kind imputation engine known as “BEAGLE 5.1.”
AccuHLA® expands upon the CookHLA® method by applying additional techniques to enhance the results depending on the ethnicity of the data inputted. The main algorithm behind AccuHLA® imputes the HLA data with several different reference panels depending on the ethnicity of the target sample, then merges the results for more accurate imputation.

PROTECTion®- Genomic Encryption

In recent years, research has shown that disease risk is not based on one single gene but is also influenced by various genes acting together. To truly understand actual disease risk, we must look at information from the whole genome.
That’s why Olive uses our state-of-the-art, whole-genome PRomiSe® technology to provide a highly accurate and comprehensive analysis of what is known as your “Polygenic Risk Score,” or PRS. The PRomiSe® pipeline is a stable and robust method for simultaneously calculating a PRS for multiple phenotypes.

Explore our knowledge of genetics in detail

Nature communications

Accurate imputation of human leukocyte antigens with CookHLA

Here we report an accurate HLA imputation method, CookHLA, which has superior imputation accuracy compared to previous methods.

Learn more

American Journal of Human Genetics

PLEIO: a method to map and interpret pleiotropic loci with GWAS summary statistics

Identifying and interpreting pleiotropic loci is essential to understanding the shared etiology among diseases and complex traits.

Learn more

American Journal of Human Genetics

Accurate and Fast Multiple-Testing Correction in eQTL Studies

The advent of RNA sequencing (RNA-seq) and expression microarrays has allowed studies to accurately quantify expression levels of genes in humans and many model organisms.

Learn more